Corporate Profile

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Presentations

Minimum 15 minutes delayed. Source: LSEG

News Releases

Events

SEC Filings

Quarterly report which provides a continuing view of a company's financial position
10-Q
Report of unscheduled material events or corporate event
8-K
Official notification to shareholders of matters to be brought to a vote ("Proxy")
DEF 14A